methylphenidate

(redirected from Methylin)
Also found in: Dictionary, Thesaurus.

methylphenidate

 [meth″il-fenĭ-dāt]
a mild central nervous system stimulant; the hydrochloride salt is administered orally in the treatment of attention-deficit/hyperactivity disorder and narcolepsy.

methylphenidate

(mĕth′əl-fĕn′ĭ-dāt′, -fē′nĭ-)
n.
A drug, C14H19NO2, chemically related to amphetamine, that acts as a mild stimulant of the central nervous system and is used in its hydrochloride form to treat attention deficit hyperactivity disorder and narcolepsy.

methylphenidate

An amphetamine-derived CNS stimulant.
 
Adverse effects
Decreased appetite—10–15% of children have major weight loss; insomnia—most suffer sleep delay; abdominal pain; headaches; dry mouth; dizziness; depression, tachycardia; a proposed link to decreased growth is uncertain.
 
Indications for
Hyperactivity, ADD, childhood narcolepsy.

methylphenidate

Ritalin® Neuropharmacology An amphetamine derived CNS stimulant used to control ADD and hyperactivity in children Adverse effects ↓ Appetite, 10-15% of children have major weight loss; insomnia–most suffer sleep delay, abdominal pain, headaches, dry mouth, dizziness, depression, tachycardia; link with ↓ growth is uncertain Used for Hyperactivity; narcolepsy; ADD. See Amphetamine.

methylphenidate

A nervous system stimulant drug that, paradoxically, has been found effective in the management of ATTENTION-DEFICIT HYPERACTIVITY DISORDER in children. A brand name is Ritalin. The current consensus of opinion on the use of this drug for this purpose is that it is grossly over-prescribed, especially in the USA.
References in periodicals archive ?
The recall does not include Methylin oral solution (5 mg/5 mL and 10 mg/5 mL).
Several long-acting forms of methylphenidate (Concerta, Metadate CD, Methylin ER, and Ritalin SR) are now on the market.
Breckenridge also introduced methylphenidate solution, the generic version of Methylin, which was filed with a Paragraph IV certification under the Hatch-Waxman Act.
The ruling will require the following 15 products to be dispensed with new patient medication guides: Adderall tablets, Adderall XR extended-release capsules, Concerta extended-release tablets, Daytrana transdermal system, Desoxyn tablets, Dexedrine Spansule capsules and tablets, Focalin tablets, Focalin XR extended-release capsules, Metadate CD extended-release capsules, Methylin oral solution, Methylin chewable tablets, Ritalin tablets, Ritalin SR sustained-release tablets, Ritalin LA extended-release capsules, and Strattera capsules.
Stimulant drugs--such as methyl-phenidate (Ritalin, Concerta, Metadate, and Methylin)-remain the preferred method to date for treating ADHD, Dr.
Stimulant drugs--such as methylphenidate (Ritalin, Concerta, Metadate, Methylin)--remain the preferred treatment for ADHD, Dr.
has expanded the Methylin (methyl phenidate) chewable tablets recall to include all lots of the product because some tablets may contain too much or too little active ingredient.
Methylin $35,920,429.71 Teva USA Clarithromycin ER $35,895,162.63 Url Felodipine ER $35,706,081.95 Teva USA Ciprofloxacin HCl $35,656,036.02 Perrigo Co.
is recalling one lot of Methylin CT (methylphenidate HCl) chewable tablets (5 mg) because the lot might contain up to three times the active ingredient.
It's not a first-line drug yet." Stimulant drugs--such as methylphenidate (Concerta, Metadate ER, Ritalin, and Methylin; the latter two have both regular or extended release formulations)--are the preferred method to date for treating ADHD.
Beyond CNS and addiction therapy Mallinckrodt is developing several ADHD products, which will provide further therapeutic options for clinicians in addition to the supplier's current ADHD treatment mainstay, Methylin methylphenidate HCI tablets USP.